Tridem Pharma
Entry
2011
Hold
6yr
Exit
2017
Who owns Tridem Pharma?
Tridem Pharma is a French Pharma company, now owned by Fosun Pharma, which acquired it in 2017 from Paluel-Marmont Capital.
Hand-verified · updated 2026-07-16
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
Fosun Pharma
Exit Year
2017
More from Paluel-Marmont Capital Fund
Other portfolio companies in the same fund.
TapNation
Active
Gaming
France· 2023
France· 2023Snetor
Active
IndustrialsFrance· 2020
France· 2020Quadrilatere
Active
Business ServicesFrance· 2019
France· 2019
Sogetrel
Exited 2021
TelecomFrance· 2018
France· 2018to Latour Capital and Andera Partners
Anaveo
Exited 2016
Business ServicesFrance· 2013
France· 2013to Bridgepoint Development Capital
Avidom
Exited 2016
HealthcareFrance· 2012
France· 2012to Azulis Capital
More PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns Tridem Pharma?
Tridem Pharma is now owned by Fosun Pharma, which acquired it in 2017 from Paluel-Marmont Capital.
When did Fosun Pharma acquire Tridem Pharma?
Fosun Pharma acquired Tridem Pharma in 2017, buying from Paluel-Marmont Capital.
Who did Tridem Pharma sell to?
Paluel-Marmont Capital sold Tridem Pharma to Fosun Pharma in 2017 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue